Mutations in Nf1 and subsequent hyperactivation of downstream signaling pathways of RAS-MEK1/2-ERK1/2 and PI3K-AKT-mTOR are necessary but not sufficient to drive the transformation of neurofibromas to MPNSTs [47, 48]. The gene discussed is MTOR; the disease is plexiform neurofibroma.